Daniela Weiskopf

Active 2006–2026

143
Papers
34,976
Citations
72
h-index
140
i10-index

Citations

Citations per year for Daniela Weiskopf1974: 2 citations1991: 2 citations2001: 1 citations2002: 6 citations2003: 3 citations2004: 2 citations2005: 5 citations2006: 7 citations2007: 3 citations2008: 12 citations2009: 15 citations2010: 46 citations2011: 46 citations2012: 43 citations2013: 70 citations2014: 68 citations2015: 89 citations2016: 121 citations2017: 168 citations2018: 170 citations2019: 520 citations2020: 1,777 citations2021: 3,753 citations2022: 3,711 citations2023: 1,614 citations2024: 1,693 citations2025: 674 citations2026: 26 citations1975–1990: no citations, so these years are not shown1992–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,652 citing papers, 24.3% of this breakdownChina: 1,261 citing papers, 8.4% of this breakdownUnited Kingdom: 1,065 citing papers, 7.1% of this breakdownGermany: 838 citing papers, 5.6% of this breakdownItaly: 620 citing papers, 4.1% of this breakdownCanada: 467 citing papers, 3.1% of this breakdownFrance: 464 citing papers, 3.1% of this breakdownAustralia: 437 citing papers, 2.9% of this breakdownIndia: 395 citing papers, 2.6% of this breakdownSpain: 345 citing papers, 2.3% of this breakdownNetherlands: 338 citing papers, 2.3% of this breakdownSwitzerland: 301 citing papers, 2% of this breakdown
0%24.3%Other 32.2%

Fields

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology14.6%
  • Immunology and Microbiology9.1%
  • Neuroscience2.7%
  • Mathematics1.3%
  • Agricultural and Biological Sciences0.4%
  • Other1.7%

Topics

  • SARS-CoV-2 and COVID-19 Research17.1%
  • COVID-19 Clinical Research Studies10.9%
  • vaccines and immunoinformatics approaches5%
  • Immunotherapy and Immune Responses3.9%
  • Long-Term Effects of COVID-193.5%
  • SARS-CoV-2 detection and testing2.2%
  • Other57.4%

Coauthors

All papers

Open in search
  1. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 4,049

  2. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 1,987

  3. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. A. McLaughlin, Justine C. Williams, Sharon Adamski, Oliva Kuthuru, The UPenn COVID Processing Unit‡, Ian Frank, Michael R. Betts, Laura A. Vella, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Scott E. Hensley, Miles P. Davenport, Paul Bates, Eline T. Luning Prak, Allison R. Greenplate, E. John Wherry - Science 2021 cited by 947

  4. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

    Authors: , , , , , , , , , , , , , , , , , , , , - Science 2021 cited by 3,022

  5. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

    Authors: , , , , , , , , , , , , , , , , - Cell 2022 cited by 927

  6. Induction of autophagy by spermidine promotes longevity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2009 cited by 1,654

  7. T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 901

  8. Properties of MHC Class I Presented Peptides That Enhance Immunogenicity

    Authors: , , , , , , , - PLoS Computational Biology, PLoS Comput. Biol. 2013 cited by 936

  9. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Diamond - Cell 2020 cited by 635

  10. T cell responses to SARS-CoV-2 spike cross-recognize Omicron

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Houriiyah Tegally, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Robert J. Wilkinson, Túlio de Oliveira, Linda‐Gail Bekker, Glenda Gray, Veronica Ueckermann, Theresa M. Rossouw, Michael T. Boswell, Jinal N. Bhiman, Penny L. Moore, Alex Sigal, Ntobeko Ntusi, Wendy A. Burgers, Catherine Riou - Nature 2022 cited by 626

  11. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2020 cited by 1,295

  12. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

    Authors: , , , , , , , , , , , , , , - Cell 2020 cited by 600

  13. Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Allison R. Greenplate, E. John Wherry - Immunity 2021 cited by 520

  14. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

    Authors: , , , , , , , , - Science 2021 cited by 353

  15. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 443

  16. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 543

  17. Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome

    Authors: , , , , , , , , , , , , , - Science Immunology 2020 cited by 997

  18. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2021 cited by 675

  19. The aging of the immune system

    Authors: , , - Transplant International 2009 cited by 919

  20. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 626

  21. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fred Vadivieso, Ashley Kloter, Stephanie DerOhannessian, Teo Tran, Linda Morrel, Ned Haubein, Joseph Dunn, Anurag Verma, Colleen Morse, Marjorie Risman, Renae Judy, Shefali S. Verma, Yuki Bradford, Scott Dudek, Theodore Drivas, Oliva Kuthuru, Jeanette Dougherty, Sharon Adamski, Sherea Long, Macy Kee, Cynthia Clendenin, Ricardo da Silva Antunes, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Alexander C. Huang, Daniel J. Rader, Scott E. Hensley, Paul Bates, Allison R. Greenplate, E. John Wherry - Nature Immunology 2023 cited by 107

  22. Immune signatures underlying post-acute COVID-19 lung sequelae

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2021 cited by 187

  23. Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2022 cited by 438

  24. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

    Authors: , , , , , , - Cell Host & Microbe 2021 cited by 354